UNSPSC 51351610: Estrone

This classification denotes an estrogen with the molecular formula C18H22O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2DI9HA706A, chemically known as 1,3,5(10)-estratrien-3-ol-17-one but generally known as estrone, which bears US NIH Compound Identifier 698. European Medicines Agency schedules Estrone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07251MIG. The term ESTRONE is an International Non-Proprietary Name.

UNSPSC 51351610 Estrone, a Commodity code, encompasses pharmaceutical active ingredients and finished-form products sourced through state and local cooperative purchasing vehicles, specifically generic pharmaceuticals and over-the-counter products supplied to participating government facilities. State and local governments buy estrone and related hormone-therapy pharmaceuticals primarily through multi-state cooperative agreements that aggregate demand across state agencies, counties, municipalities, and subordinate health and social-services facilities. The procurement structure emphasizes volume pricing, compliance with cGMP and Drug Supply Chain Security Act requirements, and mandatory distribution through established pharmaceutical wholesalers with chargeback systems and EDI capability. Issuers include state departments of administration and multistate purchasing alliances serving state and local members across multiple jurisdictions.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued a Request for Proposal in January 2026 (S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. The solicitation targets manufacturers supplying products through three authorized wholesalers — AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC — with contract awards effective July 1, 2026 and a two-year initial term. The RFP weights price competitiveness at 75 percent of the evaluation, with the remaining 25 percent distributed across fixed pricing, administrative compliance, EDI capability, and the 3 percent administrative fee structure. Vendors must maintain commercial general liability insurance of $5,000,000 per occurrence and comply with performance penalty provisions ranging from $200 to $1,500 per violation for reporting delays or missed onboarding timelines. The procurement serves participating state and local government facilities in Minnesota and Oregon.